Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-005913-37Phase 3Completed
Phase 3, randomised trial of gentamicin in Meniere Disease (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Dizziness Handicap Inventory (DHI) score. Started Dec 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-005913-37.